Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Loading…
Programmed Death Ligand 1 (PD-L1) Gene Variants Contribute to Autoimmune Addison’s Disease and Graves’ Disease Susceptibility
Mitchell, Anna L., Cordell, Heather J., Soemedi, Rachel, Owen, Kate, Skinningsrud, Beate, Wolff, Anette Bøe, Ericksen, Martina, Undlien, Dag, Husebye, Eystein, Pearce, Simon H. S.
Published in The journal of clinical endocrinology and metabolism (01.12.2009)
Published in The journal of clinical endocrinology and metabolism (01.12.2009)
Get full text
Journal Article
Loading…
Comprehensive population pharmacokinetic modelling of sugemalimab, an anti‐programmed death‐ligand 1 (PD‐L1) human monoclonal antibody, in patients with solid tumours or lymphomas across multiple Phase I–III studies
Wang, Kun, Pan, Chaohsuan, Xu, Fengyan, Tse, Archie N., Sheng, Yucheng
Published in British journal of clinical pharmacology (01.03.2025)
Published in British journal of clinical pharmacology (01.03.2025)
Get full text
Journal Article
Loading…
Assessment of programmed death ligand 1 (PD-L1) expression in cervical intraepithelial neoplasia and carcinoma cervix
Shelly, Divya, Sharma, Pragya, Mishra, P.S., Mulajker, Deepak, Bisht, Niharika, Mukundan, Hari, Kumar, Shiv
Published in Medical journal. Armed Forces India (01.07.2025)
Published in Medical journal. Armed Forces India (01.07.2025)
Get full text
Journal Article
Loading…
Programmed death-ligand 1 (PD-L1) and programmed cell death protein 1 (PD-1) expression in bladder cancer (BC): Differences in recurrent, progressive, and metastatic disease
Hegele, Axel, Wahl, Franziska, Rexin, Peter, Nimphius, W, Hofmann, Rainer, Haenze, Joerg
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Loading…
OSTPDL1: A phase II study of avelumab, a monoclonal antibody targeting programmed death-ligand 1 (PD-L1) in adolescent and young adult patients with recurrent or progressive osteosarcoma
Bishop, Michael William, Kaste, Sue C., Sykes, April, Pan, Haitao, Dela Cruz, Filemon S., Whittle, Sarah, Mascarenhas, Leo, Thomas, Paul G, Youngblood, Ben, Harman, Jennifer L, Wang, Lisa L., Meyers, Paul A., Pappo, Alberto S.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Loading…
Hubungan ekspresi programmed death-ligand 1 (PD-L1) dengan profil klinikopatologi karsinoma nasofaring undifferentiated subtype di RSUP Prof. dr. I.G.N.G. Ngoerah Denpasar
Megadasari, Anak Agung Prami, Sumadi, I Wayan Juli, Dewi, I Gusti Ayu Sri Mahendra
Published in Intisari Sains Medis (ISM) (Manado) (15.06.2024)
Published in Intisari Sains Medis (ISM) (Manado) (15.06.2024)
Get full text
Journal Article
Loading…
Programmed death-ligand 1 (PD-L1) polymorphisms as predictive biomarkers for the development of liver cirrhosis and hepatocellular carcinoma in HCV Egyptian patients
Hassan, Marwa, Attia, Mohammed Saad, Ali-Eldin, Zainab, El Attar, Gamal, Elzallat, Mohamed, Saad, Hany Haroun Kaisar, Isaac, Amira
Published in Tumour virus research (01.12.2022)
Published in Tumour virus research (01.12.2022)
Get full text
Journal Article
Loading…
36 Digital Whole Slide Image (WSI) scoring is equivalent to microscope glass slide scoring for evaluation of programmed death-ligand 1 (PD-L1) expression across multiple tumor indications
Adams, Micki, Moquin, Deanna, Littrell, Joshua, Milo, Jay, Hund, Stephanie, Apostolaki, Angeliki
Published in Journal for immunotherapy of cancer (01.11.2021)
Published in Journal for immunotherapy of cancer (01.11.2021)
Get full text
Journal Article
Loading…
Analysis of Programmed Death Ligand 1 (PD-L1) Expression in Diffuse Large B Cell Lymphomas (DLBCL) in HIV-Negative Versus HIV-Positive Patients
Chao, Chun, Young, Patricia A, Xu, Lanfang, Silverberg, Michael J., Said, Jonathan W., Timmerman, John M.
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
Loading…
The impact of a pathologist’s personality on the interobserver variability and diagnostic accuracy of predictive PD-L1 immunohistochemistry in lung cancer
Butter, Rogier, Hondelink, Liesbeth M., van Elswijk, Lisette, Blaauwgeers, Johannes L.G., Bloemena, Elisabeth, Britstra, Rieneke, Bulkmans, Nicole, van Gulik, Anna Lena, Monkhorst, Kim, de Rooij, Mathilda J., Slavujevic-Letic, Ivana, Smit, Vincent T.H.B.M., Speel, Ernst-Jan M., Thunnissen, Erik, von der Thüsen, Jan H., Timens, Wim, van de Vijver, Marc J., Yick, David C.Y., Zwinderman, Aeilko H., Cohen, Danielle, 't Hart, Nils A., Radonic, Teodora
Published in Lung cancer (Amsterdam, Netherlands) (01.04.2022)
Published in Lung cancer (Amsterdam, Netherlands) (01.04.2022)
Get full text
Journal Article
Loading…
Programmed Death Ligand 1 (PD-L1) Gene Variants Contribute to Autoimmune Addison’s Disease and Graves’ Disease Susceptibility
Mitchell, Anna L., Cordell, Heather J., Soemedi, Rachel, Owen, Kate, Skinningsrud, Beate, Wolff, Anette Bøe, Ericksen, Martina, Undlien, Dag, Husebye, Eystein, Pearce, Simon H. S.
Published in Molecular endocrinology (Baltimore, Md.) (01.11.2009)
Published in Molecular endocrinology (Baltimore, Md.) (01.11.2009)
Get full text
Journal Article
Loading…
Loading…
Loading…
The multifaceted nature of diabetes mellitus induced by checkpoint inhibitors
Marchand, Lucien, Disse, Emmanuel, Dalle, Stéphane, Reffet, Sophie, Vouillarmet, Julien, Fabien, Nicole, Thivolet, Charles, Cugnet-Anceau, Christine
Published in Acta diabetologica (01.12.2019)
Published in Acta diabetologica (01.12.2019)
Get full text
Journal Article
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…